Get started
Author

Franziska Schneppenheim

Observed name: F Schneppenheim
ORCID: 0009-0001-9545-5192
Observed ORCID: 0009-0001-9545-5192
OpenAlex ID: A5092014409
A functional single-cell metabolic survey identifies Elovl1 as a target to enhance CD8+ T cell fitness in solid tumours
2025 · Samantha Pretto, Qian Yu, et al. · Nature Metabolism · 18
Stressed out: NKp46 binds ecto‐calreticulin
2023 · Dillon Corvino, Denise Rommel, et al. · Immunology and Cell Biology · 2
PDF
Engineered endothelial cell grafts form functional anastomoses and enable recruitment of intravenously delivered human T cells in CAM tumor models
2026 · Anna-Sophie Hartel, Anna Stettner, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
P02.10 Development of Nectin-2 specific Nano-CARs for the treatment of melanoma
2026 · C Birr, G Saavedra, et al. · Poster presentations
PDF
P02.03 Targeting CDCP1 with single-domain antibody-based CAR T cells to treat solid tumors
2026 · F Schneppenheim, M Saponaro, et al. · Poster presentations
PDF
Type I Interferon Drives a Cellular State Inert to TCR‐Stimulation and Could Impede Effective T‐Cell Differentiation in Cancer
2024 · Dillon Corvino, Martin Batstone, et al. · European Journal of Immunology
PDF
Author response for "Type I Interferon Drives a Cellular State Inert to TCR‐Stimulation and Could Impede Effective T‐Cell Differentiation in Cancer"
2024 · Dillon Corvino, Martin Batstone, et al.
Author response for "Type I Interferon Drives a Cellular State Inert to TCR‐Stimulation and Could Impede Effective T‐Cell Differentiation in Cancer"
2024 · Dillon Corvino, Martin Batstone, et al.
Works count: 8
Citation count: 20
H-index: 2
I10-index: 1
Year
Topic
Type